Forced Abortion Prevention and Accountability Act
- Sponsor
- Rep. Messmer, Mark B. [R-IN-8]
- Committees
- Judiciary Committee (primary)
- Last action
- Dec 4, 2025
Bottom line
This bill establishes new federal criminal and civil penalties for the non-consensual administration of abortion-inducing drugs, aiming to protect pregnant women from forced abortions and hold perpetrators accountable.
What it actually does
This bill creates a new federal crime for knowingly and intentionally administering an abortion-inducing drug to a pregnant woman without her informed consent, provided the drug was shipped in interstate commerce. It establishes severe penalties, including fines and up to 25 years imprisonment, with enhanced penalties if the act results in serious bodily injury or death. Additionally, the bill creates a federal civil remedy, allowing victims to sue for damages.
Proponents argue
Proponents argue that this bill is a crucial measure to protect vulnerable pregnant women from coercion and violence, ensuring that abortion-inducing drugs are only administered with explicit, informed consent. They emphasize the need for federal intervention to prevent forced abortions and provide robust accountability for those who violate a woman's bodily autonomy.
Opponents contend
Opponents might argue that existing state and federal laws already address assault, battery, and coercion, making this bill an unnecessary federal overreach into reproductive healthcare. They could contend that the bill's broad definitions, particularly concerning 'conspires to commit an offense,' risk criminalizing legitimate medical activities or creating a chilling effect on access to care, even for consensual abortions.
The bill is concise and clearly written, allowing an informed reader to quickly grasp its core provisions and implications.
Section 2(a), adding new 18 U.S.C. 1532(a)
Prohibition on Non-Consensual Administration of Abortion-Inducing Drugs
This provision establishes a new federal crime for any individual who knowingly and intentionally administers an abortion-inducing drug to a pregnant woman without her informed consent, provided the drug was involved in interstate or foreign commerce. Violators face fines under title 18 and imprisonment for up to 25 years, or both. This aims to directly criminalize acts of forced abortion using medication.
Supporters argue
Supporters argue this provision directly addresses a severe form of coercion and violence against pregnant women, providing a specific federal tool to prosecute those who force abortions using medication, thereby enhancing women's safety and autonomy.
Critics contend
Critics might argue that existing state and federal laws against assault and battery are sufficient to address such acts, and this provision unnecessarily federalizes crimes typically handled at the state level, potentially leading to over-prosecution or misapplication.
Tradeoffs
The provision balances the desire to protect pregnant women from forced medical procedures with concerns about federal expansion into areas traditionally governed by state criminal law.
Section 2(a), adding new 18 U.S.C. 1532(c)
Enhanced Penalties for Serious Bodily Injury or Death
This section mandates enhanced penalties if the non-consensual administration of an abortion-inducing drug results in serious bodily injury or death to the pregnant woman. In such cases, the offender faces an additional term of imprisonment of up to 25 years, which is added to any other term of imprisonment imposed under the primary offense.
Section 2(a), adding new 18 U.S.C. 1532(d)
Civil Remedy for Victims of Forced Abortions
This provision creates a federal civil cause of action, allowing a woman who was administered an abortion-inducing drug without her informed consent to sue the perpetrator (or those who attempted or conspired) in federal court. She can seek objectively verifiable money damages for all injuries, statutory damages equal to three times the cost of injuries, and punitive damages. Prevailing plaintiffs are awarded attorney's fees, while prevailing defendants can receive fees if the suit is found to be frivolous.
Section 2(a), adding new 18 U.S.C. 1532(e)
Key Definitions for Enforcement and Scope
This section defines critical terms for the bill's application. 'Abortion' is defined broadly as intentionally killing an unborn child or terminating a pregnancy with specific exceptions. 'Abortion-inducing drug' explicitly includes mifepristone and misoprostol. Crucially, 'conspires to commit an offense' is expanded to include selling, sending, or giving an abortion-inducing drug without taking 'reasonable measures' to ensure the recipient is a pregnant woman wishing to obtain an abortion. 'Informed consent' is defined as voluntary, knowing agreement after full disclosure of risks and consequences.
The definition of 'conspires to commit an offense' includes 'selling, sending by shipping or mailing, or giving an abortion-inducing drug without taking reasonable measures to ensure the individual requesting the drug is a pregnant woman wishing to obtain an abortion.'
Section 2(a), adding new 18 U.S.C. 1532(e)(3)
Why it matters:While definitions are a standard place for such details, the specific inclusion of 'reasonable measures' and the broad scope of 'selling, sending... or giving' expands the net of potential criminal liability beyond direct administration. This could be seen as an intentional broadening of scope that might receive less scrutiny when placed in a definitions section rather than the core criminal offense description.
Case for: Proponents would argue this is essential to prevent indirect facilitation of forced abortions, ensuring that those who supply the drugs are also held accountable if they fail to exercise due diligence. It closes a potential loophole that could be exploited by perpetrators.
Case against: Opponents might argue this places an undue and ambiguous burden on distributors, potentially leading to criminalization of individuals or entities not directly involved in coercion but who fail to meet an undefined 'reasonable measures' standard. It could also create a chilling effect on access to these drugs for legitimate purposes.
Estimated impact: Significantly expands the range of individuals and entities potentially subject to federal criminal and civil penalties under the Act, impacting pharmacists, online pharmacies, and other distributors by requiring new verification protocols.
Amends the chapter heading for chapter 74 of title 18, United States Code, from 'PARTIAL-BIRTH ABORTIONS' to 'ABORTIONS.' It also updates the corresponding entry in the table of chapters.
Section 2(c)
Why it matters:While standard legislative practice for updating chapter headings when new sections broaden the scope, the change from a specific procedure ('Partial-birth abortions') to the more general 'Abortions' reflects a broader legislative intent to regulate abortion more generally under this chapter. This subtle shift in federal legal categorization could be seen as a significant, though understated, policy move.
Case for: Proponents would argue this is a necessary and logical update to the chapter heading to accurately reflect the new, broader scope of federal regulation concerning abortions introduced by this bill, moving beyond a single procedure.
Case against: Opponents might view this as a symbolic but significant step towards federalizing more aspects of abortion regulation, moving beyond specific procedures to a more general federal oversight, which they would oppose as an infringement on states' rights or reproductive autonomy.
Estimated impact: Primarily symbolic and structural, this amendment signals a broader federal legislative intent regarding abortion regulation within the U.S. Code, impacting how future legislation and judicial interpretations might frame federal involvement in abortion.